LATEST
Intelligent Protection Management agreed to acquire AdTech ITnewJanel agreed to acquire EnCor BiotechnologyNightfood Holdings acquired Jun Long Machine IndustrialClimb Global Solutions acquired NeoVADValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range Intermediate
Open App
ClosedPublished 21 Jan 2022

Avanos Medical, Inc. /
OrthogenRx, Inc.

Avanos Medical adds OrthogenRx in a completed merger

Price
$130.0m
Stage
Closed
Source · 21 Jan 2022
See the source
01 / BuyerAvanos Medical, Inc.
02 / TargetOrthogenRx, Inc.
01

What happened

Avanos Medical, Inc. completed its merger with OrthogenRx, Inc. on January 20, 2022. OrthogenRx will operate as a wholly owned subsidiary of Avent, Inc.

The purchase price was $130.0 million in cash at closing, with up to an additional $30.0 million in contingent cash consideration tied to net sales growth during 2022 and 2023. OrthogenRx focuses on developing and commercializing treatments for knee pain caused by osteoarthritis.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Avanos Medical adds OrthogenRx in a completed merger

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.